Sintx Technologies (SINT) Gains from Investment Securities (2013 - 2014)
Sintx Technologies' (SINT) quarterly Gains from Investment Securities came in at $114000.0 in Q1 2014, down 64.26% year-on-year from $319000.0 in Q1 2013, and down 64.26% quarter-over-quarter from $319000.0 in Q1 2013.
Sintx Technologies (SINT) Gains from Investment Securities (2013 - 2014) Analysis & Trends
Sintx Technologies' Gains from Investment Securities history runs 2 years deep, the most recent figure standing at $114000.0 for Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.36 Bn | 175.06 Bn | 6.27 Bn |
| 2 | Stryker | 128.86 Bn | 125.99 Bn | 3.81 Bn |
| 3 | Medtronic | 108.02 Bn | 98.80 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.21 Bn | 66.76 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 24.11 Bn | 20.99 Bn | 2.07 Bn |
| 10 | Sintx Technologies | 6.10 Mn | 4.21 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | 114,000.00 |
| Mar 31, 2014 | 114,000.00 |
| Mar 31, 2013 | 319,000.00 |
| Mar 31, 2013 | 319,000.00 |